3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
10
Lymphoid
1
Gynecologic
1
Conditions
Hodgkin Disease
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
2
Stress Disorders, Post-Traumatic
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Heart Defects, Congenital
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
10
pembrolizumab
9
Therapeutics
8
Flow Cytometry
6
Radiotherapy
5
Gemcitabine
5
Blood Specimen Collection
5
Surveys and Questionnaires
4
Sirolimus
4
Psychiatric Rehabilitation
4
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Nivolumab
4
Methods
4
Ipilimumab
4
Filgrastim
4
Exercise
4
Drug Therapy
4
Doxorubicin
4
Capecitabine
4
copanlisib
3
aldesleukin
3
Rituximab
3
Polymerase Chain Reaction
3
Immunologic Techniques
3
Immunoglobulin G
3
Immunoenzyme Techniques
3
Fluorodeoxyglucose F18
3
Early Intervention, Educational
3
Disulfides
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Exercise Test
×
Lymphoid
×
Clear all
NCT05595577
2026-03-20
PALS
Wake Forest University Health Sciences
Phase NA
Recruiting
110 enrolled